CSS
PYXS icon

Cubist Systematic Strategies’s Pyxis Oncology PYXS Stock Holding History

Cubist Systematic Strategies’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$73.4K Buy
+33,061
New +$47.6K ﹤0.01% 2813
2023
Q4 		– Sell
-13,312
Closed -$26.5K – 4003
2023
Q3 		$26.5K Sell
13,312
-38,205
-74% -$88.5K ﹤0.01% 3079
2023
Q2 		$132K Buy
51,517
+49,948
+3,183% +$158K ﹤0.01% 2930
2023
Q1 		$6.29K Buy
+1,569
New +$3.13K ﹤0.01% 3745

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cubist Systematic Strategies's PYXS Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Pyxis Oncology (PYXS) in Q3 2025: 33,061 shares worth $73.4K. The stake represents ﹤0.01% of the portfolio and ranks #2813 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in PYXS as recently as Q3 2023.

Cubist Systematic Strategies first reported a position in PYXS in Q1 2023 and has held it in 4 quarters since. The position peaked at $132K in Q2 2023. 73 funds tracked by Wall St. Rank hold PYXS as of Q3 2025.

  • Cubist Systematic Strategies held 33,061 shares of Pyxis Oncology worth $73.4K as of Q3 2025.
  • Pyxis Oncology was a new Cubist Systematic Strategies position in Q3 2025.
  • Pyxis Oncology made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2813 holding.
  • Cubist Systematic Strategies first reported a position in Pyxis Oncology in Q1 2023 and has held it in 4 quarters since.
  • Cubist Systematic Strategies's Pyxis Oncology position peaked at $132K in Q2 2023.
  • 73 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.